(2R, 3S) -2-{(1R) -1-[3,5-BIS (TRIFLUOROMETHYL)PHENYL] ETHOXY}-3-(4-FLUOROPHENYL) MORPHOLINE HYDROCHLORIDE CAS 171482-05-6

Pwodwi Deskripsyon:

Non pwodwi:

(2R, 3S) -2-{(1R) -1-[3,5-BIS (TRIFLUOROMETHYL)PHENYL] ETHOXY}-3-(4-FLUOROPHENYL) MORPHOLINE HYDROCHORIDE CAS PA GEN OKENN: 171482-05-6

 

Sinonim:

(2R, 3S) -2-[(1R) -1-[3,5-bis (trifluoromethyl)phenyl]ethoxyl]-3-(4-fluorophenyl) Morpholine hydrochloride (1:1);

Aprepitan HCL;

Aprepitan M2 Metabolite (1R, 2R, 3S);

 

Chimik & Pwopriyete fizik:

Aparans: blan a solid blan

Assay: ≥99.00%

Bouyi pwen: 387.9 ° C nan 760 mmHg

Flash Pwen: 188.4 ° C

 

5-[[2R, 3S) -2-[(1R) -1-[3, 5-bis (trifluoromethyl) fizyozik] ethoxyl] -3- (4-fluorophenyl) -4-morphoryl] methyl]-1, 2-dihydro-3H-1, 2, chimik4-triazol-3-ketone Li se yon dwog antimetik devlope pa Merck Ozetazini pou prevansyon an nan egi ak reta vomi pandan chimyoterapi. Syans klinik yo te montre ke administrasyon advant nan aprepitan ka siyifikativman kontwole chimyoterapi-pwovoke ke plen ak vomisman (CINV) sentom nan itilize nan modere ak tre emetik dwog chimyoterapi.

 

Si ou enterese nan pwodwi nou yo oswa ou gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

Pwodwi anba patant yo ofri pou R & D rezon selman. Sepandan, denye responsablite a bay manti selman ak achte a.

Baj popilè: (2r, 3s) -2-{(1r) -1-[3,5-bis (trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl) morpholine hydrochoride cas 171482-05-6, manifaktire, founise, faktori, achte, nan stock

• On: 2R, 3S) -2-[(1R) -1-[3,5-Bis (trifluoromethyl)phenyl]ethoxyl]-3-(4-fluorophenyl) morpholine 4-methylbenzenesulfonate CAS 20000-59-59-5
• Pwochen: (2R) -4-BENZYL-2-{(1R) -1-[3,5-BIS (TRIFLUOROMETHYL) PHENYL] ETHOXY}MORPHOLIN-3-YON SEL CAS 287930-75-0